Bottom line
Strictly speaking, vitamin D does not behave much like a vitamin. The body can make it in the skin with the help of sunlight, and it is closer to the precursor of a hormone 65.
Shortfall is genuinely common. On U.S. figures, about three in ten people are deficient, and about another four in ten sit at an insufficient level 5.
The hope that "taking it prevents the big diseases" has been cooled. In the largest randomized trial so far, more than twenty thousand people took a supplement for several years, and neither cancer nor cardiovascular events fell 8.
In observational studies, people with low blood 25-hydroxyvitamin D have a clearly higher risk of death from all causes 9. Its role in regulating the immune system also has solid mechanism research 7.
The views broadly agree that deficiency is worth taking seriously. They differ on how high the target sits, and on whether healthy people take it as a routine 235.
In 2024 the Endocrine Society's guideline turned toward "empiric supplementation" by group. People 75 and older, pregnancy, and high-risk prediabetes are among those most likely to benefit. The guideline also states that the amounts used in the trials differ widely, and that a suitable amount is still unclear 11.
What it is
Vitamin D is a family of fat-soluble molecules. The two that matter most for human health are D2 (ergocalciferol) and D3 (cholecalciferol). D2 comes mainly from plants and fungi. D3 comes from sunlight, oily fish, egg yolk, and some fortified foods 5.
Making it is a three-step line. Step one is in the skin: ultraviolet B in sunlight turns a cholesterol raw material into D3. Step two is in the liver: D3 becomes 25-hydroxyvitamin D, abbreviated 25(OH)D, the main form in the circulation. Step three is in the kidney: it becomes 1,25-dihydroxyvitamin D, calcitriol, the active hormone the body actually uses 5.
In an interview, critical-care physician Roger Seheult says vitamin D "it is not technically a vitamin," but "a fat-soluble steroid hormone, similar in structure to other hormones." Like other steroid hormones, it can enter the nucleus and regulate many genes 6.
About nine tenths of circulating 25(OH)D is carried by vitamin D binding protein 5. The enzymes that take part in synthesis and activation depend on magnesium. Low magnesium slows the whole line 5.
The "vitamin D" on a lab report measures 25(OH)D — the body's stores — not the active form 5. Historically it was named a vitamin because it prevented rickets in children, and the name stuck 5.
Why it matters
Its classic job is helping the gut absorb calcium and phosphorus and keeping bone mineralized. Long, severe deficiency in adults produces osteomalacia. In children it is rickets. In recent decades rickets has reappeared in parts of Southeast Asia and in infants fed only breast milk 5.
It also takes part in muscle function 5. On immunity, a review describes vitamin D as a major regulator of immune function. It activates innate immunity, helps defend against respiratory infection, and suppresses pro-inflammatory cytokines 7.
Why deficiency is widespread: sunlight is the main source, and darker skin, high latitude, winter, indoor life, and sunscreen habits all cut what the skin makes 5. Vitamin D is fat-soluble and gets "sealed" in fat tissue, so people with more body fat have less of it available 1.
On consequences, a meta-analysis of 32 studies found that the group with the lowest blood 25(OH)D, compared with the group above 30 ng/mL, had an all-cause mortality risk ratio of about 1.9 9.
On the other side, a dedicated analysis spun out of the VITAL trial of more than twenty thousand people. Confirmed autoimmune disease was the primary endpoint of that analysis, and the group taking vitamin D had a hazard ratio of 0.78 10.
Different perspectives
Main positions
A Q&A episode is a frame for evaluating supplements: effect, quality, and a person's need 2. Applied to vitamin D, that episode lists three blocks. How deficiency is defined and how a target level is set. Roles in bone and immunity, and the limits of biomarkers. How efficacy, safety, and the balance of benefit and risk are held together 2.
One account illustrates that being outdoors every day does not guarantee a sufficient level without supplementation 3.
On how high is high enough, one view states outright that there is a lot of debate about how high a vitamin D level needs to sit, and that the argument will not be settled soon 3.
A free article covers the winter slide. The higher the latitude and the longer the winter, the more easily 25(OH)D falls. Regular exercise of moderate intensity can offset that slide. In the trial cited there, the group that did not exercise saw the active form fall by about 15 percent 1. The article also notes that people with lighter skin need only a short time in the sun — about nine minutes in the study, with about a third of the skin exposed — to stimulate synthesis in a clear way, while people with more body fat have stores more easily locked in fat 1.
A supplementation topic page says vitamin D3 matters for bone health, immune function, cardiovascular function, and hormone regulation, and that limited sun and similar factors make supplementation something worth considering when the aim is to maintain the level 4.
In a long conversation about how to evaluate whether a supplement is working, one view notes that when markers such as a vitamin D level are put into biological-age tools, the measurement noise is not small. The same person can differ a lot from one test to the next 3.
The stance of that conversation matches the topic page. It is not "everyone is low, everyone takes it." It is: get the evidence and the person's situation clear first 34.
A systematic vitamin D topic page stresses the hormone-like character of vitamin D, the multi-step synthesis line, and the prevalence figure that about seven in ten Americans are insufficient or deficient 5.
On official intake standards, the page states where they come from. The RDA, the daily dietary supply figure, is set on the assumption of very little sun. The stated use is preventing rickets and osteomalacia and maintaining calcium metabolism in healthy people 5.
The page records the status dispute in detail. The Institute of Medicine treats 25(OH)D of 20 ng/mL as sufficient. The Endocrine Society sets below 20 ng/mL as deficiency and 21 to 29 ng/mL as insufficiency. The same blood, two sets of lines 5. It also warns that the test itself has method differences and can read falsely high or falsely low 5.
Material on the same platform also stresses immunity. Vitamin D activates innate immunity and suppresses pro-inflammatory signals 7. In an interview, Seheult explains that calling it a vitamin is a misnomer, and he describes a hormone mechanism in the same family as testosterone and estrogen 6.
Where views agree and differ
Three points of agreement. Deficiency is common and worth taking seriously 54. Its actions go well past bone, and the mechanism evidence for immune regulation is solid 67. Extreme deficiency harms bone and needs correcting 5.
Disagreement one is the target level. The Endocrine Society line cited in one review, hoping to reach above 30 ng/mL, sits above the Institute of Medicine's 20 ng/mL 5. One view holds that this argument is still far from consensus 3.
Disagreement two is whether healthy people take it as a routine. The main VITAL trial was negative 8. That episode lands the vitamin D discussion on the target level and the balance of benefit and risk 2. A supplementation topic page treats supplementation for people with limited sun as a reasonable path 4.
Disagreement three is whether to test widely. The Endocrine Society once favored wide testing of high-risk groups 5. The 2024 guideline has turned to a more restrained stance, concentrating resources on the groups most likely to benefit 11.
PearHealth's synthesis
What we take: vitamin D is a hormone precursor, not an ordinary nutrient. Deficiency is common. It matters for bone and immunity. People with darker skin, at high latitude, in winter, living indoors, or with more body fat are more likely to run low 51.
What we hold back: "taking it prevents cancer and cardiovascular disease" has no randomized-trial support 8. The autoimmune signal comes from an extended analysis of VITAL and still needs a dedicated trial 10. The mortality association in observational studies cannot rule out confounding. People who spend more time outdoors and are healthier overall already have higher 25(OH)D 9.
We stress one point in particular. A single number on a lab report is affected by season and by the test method 5. Do not draw a conclusion about yourself from one value. A supplement is not a case of more being better. The guideline states plainly that amounts differ widely across trials and that a suitable amount is not clear 11.
We do not sell any vitamin D supplement.
How strong is the evidence
The evidence that "vitamin D supplementation prevents cancer and cardiovascular disease" is negative. VITAL is a double-blind randomized trial: 25,871 people, median follow-up 5.3 years, a cancer hazard ratio of 0.96 in the supplement group and 0.97 for major cardiovascular events. Neither differed statistically from placebo 8. A randomized trial can speak to cause. That is its weight.
"A low level is associated with higher death risk" comes from a meta-analysis of observational studies. Pooled across 32 studies, the lowest group versus the group above 30 ng/mL had a mortality risk ratio of about 1.9 9. Observation can only point to an association. It cannot rule out confounding.
"It regulates immunity" has mechanism support. The hormone enters the nucleus and regulates genes, activates innate immunity, and suppresses pro-inflammatory signals 67. Mechanism research can show that the biology is coherent. It cannot show that supplementation prevents disease.
"Who is worth supplementing" is expert judgment. The 2024 Endocrine Society guideline uses the wording of empiric supplementation for children and adolescents, people 75 and older, pregnancy, and high-risk prediabetes, and it says plainly that trial amounts differ widely and a suitable amount is not clear 11. The evidence grade behind the guideline is weak overall. It is a pragmatic stance of acting when benefit exceeds harm.
There is also a measurement layer. 25(OH)D assays differ across methods and "can provide falsely low or high results." A single number is read with room to spare 5.
What you can do
One workable direction: figure out first whether you are in a group that tends to run low, then discuss testing and supplementation with a clinician, rather than buying a supplement and finding a reason afterward.
Things that can be done:
- Take stock of sun. High latitude, a long winter, days spent indoors, darker skin, and strict sunscreen habits are all situations that tend to run low 51.
- Put oily fish, egg yolk, and fortified foods into ordinary meals 5.
- Keep regular exercise in winter. A trial shows it can offset the seasonal slide in the active form 1.
- If 25(OH)D has been measured, record the number together with the season and the laboratory. A trend carries more information than a single point 5.
Questions worth raising with a clinician:
- Am I in a group the guideline names: 75 and older, pregnancy, high-risk prediabetes, children and adolescents 11?
- Do I have osteoporosis, malabsorption, obesity, or another situation that makes deficiency more likely 15?
- Is a 25(OH)D test warranted, and how often is it repeated 5?
- Where do total calcium, blood phosphorus, alkaline phosphatase, and magnesium sit 5?
Common misconceptions
Misconception one: daily sun means deficiency is impossible. Being outdoors every day does not guarantee a sufficient level without supplementation 3. Season, latitude, skin color, and the amount of body fat all change the result 1.
Misconception two: vitamin D supplementation prevents cancer and heart disease. The primary endpoints of the VITAL randomized trial were negative 8.
Misconception three: more is better, and a heavier amount is the safer bet. The 2024 guideline says plainly that amounts differ widely across trials, a suitable amount is not clear, and the benefit is concentrated in particular groups 11.
Misconception four: one number on the lab report is a hard marker. Methods differ and can read falsely high or falsely low, and the number also moves with the season 5.
Misconception five: vitamin D only looks after bone. Its hormone character means it can enter the nucleus and regulate genes, including a part in immune regulation 67.
How it connects to your blood work
The markers most directly tied to vitamin D are below. They are worth reading together.
- 25-hydroxyvitamin D (vitamin-d-25oh): the lead marker. It measures stores, not the active form. The same number can be judged against different lines at different laboratories 5.
- Total calcium (calcium-total): regulated by vitamin D, and worth reading next to season and the test method 5.
- Phosphate (phosphate): regulated together with calcium by vitamin D, and it can run low in long, severe deficiency 5.
- Alkaline phosphatase (alp): rises when bone turnover speeds up, a common change in long deficiency 5.
- Red-cell magnesium (magnesium-rbc): the enzymes at each activation step depend on magnesium. When magnesium is low, the efficiency of vitamin D supplementation is affected too 5.
No blood test can tell you directly how much to take. That decision combines group, season, and trend, and it belongs with a clinician 11.